High HIV incidence in men who have sex with men attending for postexposure prophylaxis: a service evaluation
Authors:
- 13 July 2016
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 93 (3) , 214-216
Abstract
Background/aims There are limited outcome data for men who have sex with men (MSM) who have received HIV postexposure prophylaxis (PEP). The objective of this service evaluation was to determine HIV incidence and repeat PEP use among MSM PEP recipients in London, UK. Methods Retrospective electronic case-note review of all MSM who were prescribed PEP between January and April 2013 at a central London sexual health service. Results 530 MSM received PEP between 1 January and 30 June 2013. Of these, 449 had more than 30 days subsequent follow-up at our service. Median age was 31 years. PEP indication was unprotected anal intercourse, 98% (receptive 88% and insertive 10%) and other, 2%. Up to 1 November 2015, total follow-up was 756 person-years. 183 users received repeat PEP. The total number of repeat PEP courses was 442. 57 MSM newly acquired HIV: the HIV incidence was 7.6 per 100 person-years. Conclusions PEP was associated with a high risk of subsequent HIV seroconversion in this cohort; this group may be appropriate candidates for pre-exposure prophylaxis.Keywords
This publication has 8 references indexed in Scilit:
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016
- Is PEP prescribed appropriately?HIV Medicine, 2015
- O1 Is pre-exposure prophylaxis for hiv prevention cost-effective in men who have sex with men who engage in condomless sex in the uk?Sexually Transmitted Infections, 2015
- The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV PreventionClinical Infectious Diseases, 2015
- Subsequent HIV Infection Among Men Who Have Sex with Men Who Used Non-Occupational Post-Exposure Prophylaxis at a Boston Community Health Center: 1997–2013AIDS Patient Care and STDs, 2015
- Uptake and Repeat Use of Postexposure Prophylaxis in a Community-Based Clinic in Los Angeles, CaliforniaAIDS Research and Human Retroviruses, 2014
- High HIV incidence among MSM prescribed postexposure prophylaxis, 2000–2009AIDS, 2012
- UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011)International Journal of STD & AIDS, 2011